Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses

Mianfu Cao, Juan Cai, Ye Yuan, Yu Shi, Hong Wu, Qing Liu, Yueliang Yao, Lu Chen, Weiqi Dang, Xiang Zhang, Jingfang Xiao, Kaidi Yang, Zhicheng He, Xiaohong Yao, Yonghong Cui, Xia Zhang and Xiuwu Bian
Cancer Biology & Medicine August 2019, 16 (3) 595-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0277
Mianfu Cao
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Cai
2Department of Kidney, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ye Yuan
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu Shi
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Wu
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qing Liu
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yueliang Yao
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lu Chen
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weiqi Dang
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiang Zhang
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingfang Xiao
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaidi Yang
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhicheng He
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaohong Yao
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yonghong Cui
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xia Zhang
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zhangxia45{at}yahoo.com bianxiuwu{at}263.net
Xiuwu Bian
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zhangxia45{at}yahoo.com bianxiuwu{at}263.net
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 16 no. 3 595-605
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2018.0277

Published By 
Cancer Biology & Medicine
History 
  • Received August 22, 2018
  • Accepted December 10, 2018
  • Published online August 1, 2019.

Copyright & Usage 
Copyright: © 2019, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Mianfu Cao1,
  2. Juan Cai2,
  3. Ye Yuan1,
  4. Yu Shi1,
  5. Hong Wu1,
  6. Qing Liu1,
  7. Yueliang Yao1,
  8. Lu Chen1,
  9. Weiqi Dang1,
  10. Xiang Zhang1,
  11. Jingfang Xiao1,
  12. Kaidi Yang1,
  13. Zhicheng He1,
  14. Xiaohong Yao1,
  15. Yonghong Cui1,
  16. Xia Zhang1⇑ and
  17. Xiuwu Bian1⇑
  1. 1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China
  2. 2Department of Kidney, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China
  1. Correspondence to: Xia Zhang and Xiuwu Bian E-mail: zhangxia45{at}yahoo.com and bianxiuwu{at}263.net
View Full Text

Cited By...

  • 45 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 16 (3)
Cancer Biology & Medicine
Vol. 16, Issue 3
1 Aug 2019
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses
Mianfu Cao, Juan Cai, Ye Yuan, Yu Shi, Hong Wu, Qing Liu, Yueliang Yao, Lu Chen, Weiqi Dang, Xiang Zhang, Jingfang Xiao, Kaidi Yang, Zhicheng He, Xiaohong Yao, Yonghong Cui, Xia Zhang, Xiuwu Bian
Cancer Biology & Medicine Aug 2019, 16 (3) 595-605; DOI: 10.20892/j.issn.2095-3941.2018.0277

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses
Mianfu Cao, Juan Cai, Ye Yuan, Yu Shi, Hong Wu, Qing Liu, Yueliang Yao, Lu Chen, Weiqi Dang, Xiang Zhang, Jingfang Xiao, Kaidi Yang, Zhicheng He, Xiaohong Yao, Yonghong Cui, Xia Zhang, Xiuwu Bian
Cancer Biology & Medicine Aug 2019, 16 (3) 595-605; DOI: 10.20892/j.issn.2095-3941.2018.0277
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Conclusions
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
  • Google Scholar

More in this TOC Section

  • A novel biguanide-derivative promotes NEDD4-mediated FGFR1 ubiquitination through BMI1 to overcome osimertinib resistance in NSCLC
  • Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters
  • Chidamide suppresses macrophage-mediated immune evasion and tumor progression in small cell lung cancer by targeting the STAT4/CCL2 signaling pathway
Show more Original Article

Similar Articles

Keywords

  • Differentially expressed genes
  • gene set enrichment analysis
  • glioblastoma prognosis
  • radiotherapy
  • temozolomide chemotherapy

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire